This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

REMD-477

REMD Biotherapeutics, Inc.

Drug Names(s): AMG 477, REMD 477, REMD477

Description: AMG 477 is an antibody antagonist to the human glucagon receptor (GCGR).

Deal Structure: Amgen and REMD
In May 2013, REMD licensed AMG477 from AMGEN for research and clinical development.


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug